Digital assistant aims to close gaps in hereditary cancer care

NCT ID NCT06914726

First seen Jul 10, 2026 ยท Last updated Jul 10, 2026

Summary

This trial tests a digital tool that helps doctors and patients manage cancer risks linked to hereditary syndromes like BRCA-related breast/ovarian cancer and Lynch syndrome. The tool provides personalized recommendations during primary care visits. Researchers compare care gaps, shared decision-making, and patient confidence between those using the tool and those receiving usual care.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Patient-centered clinical decision support (PC-CDS) tool
What this could lead to
If successful, this tool could help people with hereditary cancer syndromes get the right preventive care and make informed decisions about their health.
What could go wrong
This is a behavioral intervention study, not a drug trial. The tool may not change care patterns or improve outcomes as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENETIC VARIATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • HealthPartners Medical Group

    Minneapolis, Minnesota, 55440, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.